← Back to Search

Sahaj Samadhi Meditation (SSM) for Chronic Pain

N/A
Waitlist Available
Led By Michelle Nelson, PhD
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 0), follow-up 1 (study completion; week 12-13), follow-up 2 (week 24)
Awards & highlights

Study Summary

This trial will compare two possible treatments for depression and chronic pain that will be offered through online group video calls. One treatment option is the Health Enhancement Program (HEP), and the other is Sahaj Samadhi Meditation (SSM). The trial will use a hybrid type 1 evaluation design that primarily focuses on a single-site, single-blinded (investigator, and clinician), 12-week randomized controlled trial (RCT) comparing SSM (n=80) versus HEP (n=80) in 160 adults with depression and chronic pain.

Eligible Conditions
  • Chronic Pain
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 0), follow-up 1 (study completion; week 12-13), follow-up 2 (week 24)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 0), follow-up 1 (study completion; week 12-13), follow-up 2 (week 24) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Health and Depression Symptomology
Secondary outcome measures
Change in Pain Severity and pain-related function
Other outcome measures
Change in Health-Related Quality of Life
Change in Medication Information

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Ten to fifteen participants in the SSM arm will be trained for 4 consecutive days (2hrs/day) in the 1st week, followed by 75 min/week reinforcement sessions for 11 weeks. This standardized, manualized therapy will be delivered by certified meditation instructors. On day 1, participants will learn the nature of meditation, and then undergo personal guided meditation. Training on days 2-4 includes understanding the nature of the mind and the thoughts arising from it, guided meditations by the instructor, and a discussion of meditation processes. Weekly 75 min reinforcement sessions will include 20 minutes of guided meditation practice, and then focus on participants' experiences with meditation during the week, additional observations, and a review of relevant knowledge to support their home practice. Participants will also be encouraged to practice twice daily at home for 20 minutes per session.
Group II: Active Control GroupActive Control1 Intervention
Ten to fifteen participants in the HEP arm will participate in the program for 4 consecutive days (2hrs/day) in the 1st week, followed by 75 min/week reinforcement sessions for 11 weeks. The Health-Enhancement Program (HEP) was designed and used as a manualized active control in meditation-based intervention trials. HEP controls for several non-specific factors found in a meditation groups, including: group support and morale, behavioural activation, reduction of stigma, facilitator attention, treatment duration, and time spent on at-home practice. HEP is tailored to be structurally equivalent to SSM with similar-sized groups, meeting schedule, total contact hours, amount of home practice and encouragement to keep practice logs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sahaj Samadhi Meditation (SSM)
2019
N/A
~110

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,344 Previous Clinical Trials
26,453,309 Total Patients Enrolled
10 Trials studying Chronic Pain
7,938 Patients Enrolled for Chronic Pain
Lunenfeld Tanenbaum Research InstituteUNKNOWN
2 Previous Clinical Trials
1,272 Total Patients Enrolled
Mount Sinai Hospital, CanadaLead Sponsor
196 Previous Clinical Trials
67,500 Total Patients Enrolled
3 Trials studying Chronic Pain
451 Patients Enrolled for Chronic Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025